{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:18:07Z","timestamp":1770059887956,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.pupt.2013.06.006","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T13:20:50Z","timestamp":1372339250000},"page":"693-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle"],"prefix":"10.1016","volume":"26","author":[{"given":"Stefano","family":"Fogli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Stefanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Daniele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Testai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Calderone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Letizia","family":"Trincavelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Martini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Breschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2013.06.006_bib1","series-title":"Asthma and COPD","first-page":"639","article-title":"Corticosteroids","author":"Barnes","year":"2009"},{"key":"10.1016\/j.pupt.2013.06.006_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1465-9921-5-17","article-title":"Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review","volume":"5","author":"Kankaanranta","year":"2004","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2013.06.006_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1517\/14740330903535852","article-title":"An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids","volume":"9","author":"Salpeter","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.pupt.2013.06.006_bib4","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.200901-0055CC","article-title":"The beta-agonist saga and its clinical relevance: on and on it goes","volume":"179","author":"Taylor","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.06.006_bib5","doi-asserted-by":"crossref","first-page":"L746","DOI":"10.1152\/ajplung.00079.2009","article-title":"Mechanism regulating proasthmatic effects of prolonged homologous beta2-adrenergic receptor desensitisation in airway smooth muscle","volume":"297","author":"Nino","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pupt.2013.06.006_bib6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1476-5381.2010.01021.x","article-title":"Rosiglitazone reverses salbutamol-induced \u03b2(2)-adrenoceptor tolerance in airway smooth muscle","volume":"162","author":"Fogli","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2013.06.006_bib7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1183\/09031936.01.17303740","article-title":"Effect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma","volume":"17","author":"Grootendorst","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.06.006_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/cs0840151","article-title":"Beta 2-adrenoceptor desensitisation in cultured human airway smooth muscle","volume":"84","author":"Hall","year":"1993","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pupt.2013.06.006_bib9","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1183\/09031936.98.11061232","article-title":"Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group","volume":"11","author":"Noonan","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.06.006_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1054\/plef.2000.0167","article-title":"Involvement of LTD(4)in allergic pulmonary inflammation in mice: modulation by cysLT(1)antagonist MK-571","volume":"62","author":"Blain","year":"2000","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.pupt.2013.06.006_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2222.2003.01615.x","article-title":"Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma","volume":"33","author":"Wu","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.pupt.2013.06.006_bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pupt.2007.08.004","article-title":"Differential responses to various classes of drugs in a model of allergic rhinitis in guinea pigs","volume":"21","author":"Al Suleimani","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pupt.2013.06.006_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1164\/rccm.200912-1811OC","article-title":"Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus","volume":"182","author":"Han","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.06.006_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1465-9921-7-103","article-title":"Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in\u00a0vitro model of asthma","volume":"7","author":"Rovati","year":"2006","journal-title":"Respir Res"},{"key":"10.1016\/j.pupt.2013.06.006_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1165\/rcmb.4532","article-title":"Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse","volume":"28","author":"Eum","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2013.06.006_bib16","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.intimp.2008.06.010","article-title":"Validation of guinea pig model of allergic rhinitis by oral and topical drugs","volume":"8","author":"Bahekar","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.pupt.2013.06.006_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.acthis.2008.04.006","article-title":"The leukotriene d4 receptor antagonist, montelukast, inhibits mast cell degranulation in the dermis induced by water avoidance stress","volume":"111","author":"Cikler","year":"2009","journal-title":"Acta Histochem"},{"key":"10.1016\/j.pupt.2013.06.006_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejphar.2008.07.046","article-title":"Novel triple neurokinin receptor antagonist CS-003 inhibits respiratory disease models in guinea pigs","volume":"596","author":"Tsuchida","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pupt.2013.06.006_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/emm.2006.14","article-title":"The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model","volume":"38","author":"Muz","year":"2006","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.pupt.2013.06.006_bib20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0960-894X(98)00051-1","article-title":"A\u00a0series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of Singulair","volume":"8","author":"Guay","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pupt.2013.06.006_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1172\/JCI118084","article-title":"Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in\u00a0vivo","volume":"96","author":"Mak","year":"1995","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pupt.2013.06.006_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0922-4106(93)90070-P","article-title":"Differential down-regulation of pulmonary beta 1- and beta 2-adrenoceptor messenger RNA with prolonged in\u00a0vivo infusion of isoprenaline","volume":"247","author":"Nishikawa","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pupt.2013.06.006_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1165\/ajrcmb.10.1.8292387","article-title":"Long-term exposure to norepinephrine results in down-regulation and reduced mRNA expression of pulmonary beta-adrenergic receptors in guinea pigs","volume":"10","author":"Nishikawa","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2013.06.006_bib24","doi-asserted-by":"crossref","first-page":"L1055","DOI":"10.1152\/ajplung.00021.2008","article-title":"Prolonged heterologous beta2-adrenoceptor desensitisation promotes proasthmatic airway smooth muscle function via PKA\/ERK1\/2-mediated phosphodiesterase-4 induction","volume":"294","author":"Hu","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pupt.2013.06.006_bib25","doi-asserted-by":"crossref","first-page":"22430","DOI":"10.1074\/jbc.M803306200","article-title":"Critical role of PDE4D in beta2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts","volume":"283","author":"Bruss","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pupt.2013.06.006_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1085\/jgp.200709881","article-title":"Roles of GRK and PDE4 activities in the regulation of beta2 adrenergic signaling","volume":"131","author":"Xin","year":"2008","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.pupt.2013.06.006_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/rcmb.2007-0171OC","article-title":"A\u00a0major functional role for phosphodiesterase 4D5 in human airway smooth muscle cells","volume":"38","author":"Billington","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2013.06.006_bib28","doi-asserted-by":"crossref","first-page":"35980","DOI":"10.1074\/jbc.M204832200","article-title":"Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter","volume":"277","author":"Le Jeune","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pupt.2013.06.006_bib29","doi-asserted-by":"crossref","first-page":"e20000","DOI":"10.1371\/journal.pone.0020000","article-title":"\u03b22-Agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4D","volume":"6","author":"Trian","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2013.06.006_bib30","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1100\/tsw.2010.229","article-title":"Montelukast: more than a cysteinyl leukotriene receptor antagonist?","volume":"10","author":"Tintinger","year":"2010","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.pupt.2013.06.006_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1254\/jphs.93.347","article-title":"Evaluation of human peroxisome proliferator-activated receptor (PPAR) subtype selectivity of a variety of anti-inflammatory drugs based on a novel assay for PPAR delta(beta)","volume":"93","author":"Kojo","year":"2003","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.pupt.2013.06.006_bib32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/bjp.2008.320","article-title":"Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir","volume":"155","author":"Janneh","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2013.06.006_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2125.1995.tb05785.x","article-title":"Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers","volume":"40","author":"Schoors","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.pupt.2013.06.006_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2222.2001.00969.x","article-title":"Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or\u00a0= 6 years","volume":"31","author":"Storms","year":"2001","journal-title":"Clin Exp Allergy"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913001363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913001363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:57:24Z","timestamp":1539565044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553913001363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1094553913001363"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2013.06.006","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2013.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}